XML 21 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statement of Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative effect of change in accounting principle
Common Stock
Additional paid-in capital
Retaining earnings
Retaining earnings
Cumulative effect of change in accounting principle
Accumulated other comprehensive income
Accumulated other comprehensive income
Cumulative effect of change in accounting principle
Balance, beginning of year (in shares) at Dec. 31, 2018     25,097,408          
Balance, beginning of year at Dec. 31, 2018 $ 888,375 $ (514) $ 25 $ 203,350 $ 715,472 $ (514) $ (30,472) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 14,820       14,820      
Shares repurchased (in shares)     (258,756)          
Shares repurchased (11,700)     (11,700)        
Stock based compensation (in shares)     177,311          
Stock based compensation 2,377     2,377        
Dividends on common stock (32,662)       (32,662)      
Change in net unrealized investment appreciation [1] 56,602           56,602  
Change in liability for underfunded employee benefit plans [2] (12,978)           (12,978)  
Compensation expense and related tax benefit for stock-based award grants 6,152     6,152        
Balance, ending of year (in shares) at Dec. 31, 2019     25,015,963          
Balance, end of year at Dec. 31, 2019 910,472 $ (30) $ 25 200,179 697,116 $ (30) 13,152  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (112,706)       (112,706)      
Shares repurchased (in shares)     (70,467)          
Shares repurchased (2,741)     (2,741)        
Stock based compensation (in shares)     109,983          
Stock based compensation (71)     (71)        
Dividends on common stock (28,526)       (28,526)      
Change in net unrealized investment appreciation [1] 35,791           35,791  
Change in liability for underfunded employee benefit plans [2] 17,968           17,968  
Compensation expense and related tax benefit for stock-based award grants $ 4,992     4,992        
Balance, ending of year (in shares) at Dec. 31, 2020 25,055,479   25,055,479          
Balance, end of year at Dec. 31, 2020 $ 825,149   $ 25 202,359 555,854   66,911  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 80,594       80,594      
Shares repurchased (in shares)     (67,651)          
Shares repurchased (2,007)     (2,007)        
Stock based compensation (in shares)     94,276          
Stock based compensation 3,023     3,023        
Dividends on common stock (15,064)       (15,064)      
Change in net unrealized investment appreciation [1] (33,301)           (33,301)  
Change in liability for underfunded employee benefit plans [2] $ 20,727           20,727  
Balance, ending of year (in shares) at Dec. 31, 2021 25,082,104   25,082,104          
Balance, end of year at Dec. 31, 2021 $ 879,121   $ 25 $ 203,375 $ 621,384   $ 54,337  
[1] The change in net unrealized appreciation is net of reclassification adjustments and income taxes.
[2] The change in liability for underfunded employee benefit plans is net of income taxes.